Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial
- DOI
- 10.1016/j.vaccine.2023.10.041
- Published
- 2023-11
- Container
- Vaccine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2023.10.041,
title = {Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial},
author = {Juan Li and Li-Wei Shi and Ke Li and Li-Rong Huang and Jian-Biao Li and Yu-Lian Dong and Wei Li and Min Ji and Qing Yang and Ling-Yun Zhou and Lin Yuan and Xue-Mei Yan and Jing-Jing Chen and Zhi-Wei Jiang and Yang-Yang Qi and Rong-Cheng Li and Yan-Ping Li and Jie-Lai Xia and Bang-Wei Yu and Zhao-Jun Mo and Chang-Gui Li},
year = {2023},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2023.10.041},
url = {https://doi.org/10.1016/j.vaccine.2023.10.041}
}RIS
TY - JOUR TI - Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial AU - Juan Li AU - Li-Wei Shi AU - Ke Li AU - Li-Rong Huang AU - Jian-Biao Li AU - Yu-Lian Dong AU - Wei Li AU - Min Ji AU - Qing Yang AU - Ling-Yun Zhou AU - Lin Yuan AU - Xue-Mei Yan AU - Jing-Jing Chen AU - Zhi-Wei Jiang AU - Yang-Yang Qi AU - Rong-Cheng Li AU - Yan-Ping Li AU - Jie-Lai Xia AU - Bang-Wei Yu AU - Zhao-Jun Mo AU - Chang-Gui Li PY - 2023 JO - Vaccine DO - 10.1016/j.vaccine.2023.10.041 UR - https://doi.org/10.1016/j.vaccine.2023.10.041 ER -
APA
Li, J., Shi, L., Li, K., Huang, L., Li, J., Dong, Y., Li, W., Ji, M., Yang, Q., Zhou, L., Yuan, L., Yan, X., Chen, J., Jiang, Z., Qi, Y., Li, R., Li, Y., Xia, J., Yu, B., Mo, Z., & Li, C. (2023). Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial. Vaccine. https://doi.org/10.1016/j.vaccine.2023.10.041
Source records
- crossref · retrieved 2026-09-26T21:04:51.144Z